SBIR-STTR Award

An Ultrasound based psoriasis treatment system
Award last edited on: 10/13/05

Sponsored Program
SBIR
Awarding Agency
NIH : NIDDK
Total Award Amount
$550,000
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Thomas L Anderson

Company Information

Biopulmonics Inc (AKA: Ultrathermics Inc~Phoenix Fourteen Inc)

7126 180th Avenue Ne
Redmond, WA 98052
   N/A
   N/A
   N/A
Location: Single
Congr. District: 01
County: King

Phase I

Contract Number: 1R43AM036156-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1985
Phase I Amount
$50,000
Psoriasis is a disease for which new modalities of treatment are needed, especially for chronic, plaque-type lesions with limited skin distribution. Patients and physicians alike are frustrated because none of the existing therapies is completely satisfactory.Preliminary clinical studies indicate that psoriatic plaques, like cancer tumors, may be cleared as a result of being heated to temperatures in the hyperthermic range (42øC-46øC). Proposed is the development of a relatively simple and inexpensive hyperthermia system capable of treating lesions of psoriasis and other heat-sensitive skin diseases. The device will be a portable, self-contained, microprocessor-controlled system well suited for use in a dermatologist's office. The unit will be capable of producing tailored thermal distributions in skin tissues by dynamically and simultaneously controlling the acoustic frequency and power output of an ultrasound transducer and the temperature of the water bath that couples the energy to the body.Phase I of this project seeks to demonstrate the feasibility of this concept by fabricating a clinically useful treatment applicator and testing its performance in both instrumented phantoms and psoriatic tissues. Key to the success of this phase is the development of a transducer capable of efficiently radiating and withstanding continuous, high-power outputs over the frequency range of 5 to 10 MHz. A novel design has been conceived and its acoustical and electrical properties simulated using a proprietary transducer modeling program developed by UltraThermics.Based on Phase I results, Phase II will request funding to develop the dedicated electronics package and cooling fluid hardware necessary to conduct thermal dosimetry studies and clinical trials. From these investigations, it is anticipated that optimized treatment protocols will emerge that confirm the safety and efficacy of this new therapy, and thereby create a demand for commercial systems.

Thesaurus Terms:
Biomedical Engineering, Instrumentation Clinically Oriented, Metabolic Disorders Inborn, Psoriasis, Temperature (Body), Hyperthermia Induced, Thermotherapy (General), Therapy, Ultrasonic Therapy Biomedical Systems Automated, Computer, Design And Evaluation Of Computers (Incl. Hardware), Physical Properties, Sound Frequency, Physical Properties, Sound, Ultrasound Human, Clinical, Models, Phantom Models National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK

Phase II

Contract Number: 2R44AR036156-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1987
(last award dollars: 1988)
Phase II Amount
$500,000

Psoriasis is a disease for which new modalities of treatment are needed, especially for chronic, plague-type lesions with limited skin distribution. Patients and physicians alike are frustrated because none of the existing therapies is completely satisfactory. Preliminary clinical studies indicate that psoriatic plaques, like cancer tumors, may be cleared as a result of being heated to temperatures in the hyperthermic range (42 - 46 degrees C). Proposed is the development of a relatively simple and inexpensive hyperthermia system capable of treating lesions of psoriasis and other heat-sensitive skin diseases. Under Phase I, a family of low-loss, extremely wideband treatment applicators was developed. A significant feature of the design is that transducers with shapes and sizes well suited for treating those body parts most often affected by psoriasis can be fabricated. Initial patient trials and dosimetry studies indicate that tailored thermal distributions can easily be induced in psoriatic tissues. Phase II seeks to develop a microprocessor-controlled electronics package capable of dynamically and simultaneously controlling the acoustic frequency and power output of the ultrasound transducer and the temperature of the water cuff that couples the energy to the body, and to enter clinical trials at four research institutions. From these investigations, it is anticipated that optimized treatment protocols will emerge that confirm the safety and efficacy of this new therapy, and thereby create a demand for commercial systems.

Thesaurus Terms:
Biomedical Engineering, Instrumentation Clinically Oriented, Metabolic Disorders Inborn, Psoriasis, Physical Properties, Sound, Ultrasound, Temperature (Body), Hyperthermia Induced, Thermotherapy (General), Therapy, Ultrasonic Therapy Physical Properties, Sound, Ultrasound Biological Effects, Skin Disorders, Temperature (Body), Hyperthermia Induced, Therapy Evaluation, Human Biomedical Systems Automated, Biomedical Systems Automated, Computer Processing Of Clinical Data, Human, Clinical, Temperature Measurement